446 related articles for article (PubMed ID: 31108205)
1. Digital light processing (DLP) 3D-printing technology and photoreactive polymers in fabrication of modified-release tablets.
Kadry H; Wadnap S; Xu C; Ahsan F
Eur J Pharm Sci; 2019 Jul; 135():60-67. PubMed ID: 31108205
[TBL] [Abstract][Full Text] [Related]
2. Hydrophilic excipients in digital light processing (DLP) printing of sustained release tablets: Impact on internal structure and drug dissolution rate.
Krkobabić M; Medarević D; Cvijić S; Grujić B; Ibrić S
Int J Pharm; 2019 Dec; 572():118790. PubMed ID: 31678382
[TBL] [Abstract][Full Text] [Related]
3. Tailoring Atomoxetine Release Rate from DLP 3D-Printed Tablets Using Artificial Neural Networks: Influence of Tablet Thickness and Drug Loading.
Stanojević G; Medarević D; Adamov I; Pešić N; Kovačević J; Ibrić S
Molecules; 2020 Dec; 26(1):. PubMed ID: 33383691
[TBL] [Abstract][Full Text] [Related]
4. Formulation and characterization of immediate-release oral dosage forms with zolpidem tartrate fabricated by digital light processing (DLP) 3D printing technique.
Adamov I; Stanojević G; Medarević D; Ivković B; Kočović D; Mirković D; Ibrić S
Int J Pharm; 2022 Aug; 624():122046. PubMed ID: 35908634
[TBL] [Abstract][Full Text] [Related]
5. An Effective Technology for the Development of Immediate Release Solid Dosage Forms Containing Low-Dose Drug: Fused Deposition Modeling 3D Printing.
Gültekin HE; Tort S; Acartürk F
Pharm Res; 2019 Jun; 36(9):128. PubMed ID: 31250313
[TBL] [Abstract][Full Text] [Related]
6. Effective and simple prediction model of drug release from "ghost tablets" fabricated using a digital light projection-type 3D printer.
Tagami T; Morimura C; Ozeki T
Int J Pharm; 2021 Jul; 604():120721. PubMed ID: 34022253
[TBL] [Abstract][Full Text] [Related]
7. Digital Light Processing (DLP) 3D Printing of Atomoxetine Hydrochloride Tablets Using Photoreactive Suspensions.
Krkobabić M; Medarević D; Pešić N; Vasiljević D; Ivković B; Ibrić S
Pharmaceutics; 2020 Aug; 12(9):. PubMed ID: 32878260
[TBL] [Abstract][Full Text] [Related]
8. Stereolithographic (SLA) 3D printing of oral modified-release dosage forms.
Wang J; Goyanes A; Gaisford S; Basit AW
Int J Pharm; 2016 Apr; 503(1-2):207-12. PubMed ID: 26976500
[TBL] [Abstract][Full Text] [Related]
9. An investigation into the use of polymer blends to improve the printability of and regulate drug release from pharmaceutical solid dispersions prepared via fused deposition modeling (FDM) 3D printing.
Alhijjaj M; Belton P; Qi S
Eur J Pharm Biopharm; 2016 Nov; 108():111-125. PubMed ID: 27594210
[TBL] [Abstract][Full Text] [Related]
10. A Lower Temperature FDM 3D Printing for the Manufacture of Patient-Specific Immediate Release Tablets.
Okwuosa TC; Stefaniak D; Arafat B; Isreb A; Wan KW; Alhnan MA
Pharm Res; 2016 Nov; 33(11):2704-12. PubMed ID: 27506424
[TBL] [Abstract][Full Text] [Related]
11. 3D extrusion printing of high drug loading immediate release paracetamol tablets.
Khaled SA; Alexander MR; Wildman RD; Wallace MJ; Sharpe S; Yoo J; Roberts CJ
Int J Pharm; 2018 Mar; 538(1-2):223-230. PubMed ID: 29353082
[TBL] [Abstract][Full Text] [Related]
12. Extrusion 3D Printing of Paracetamol Tablets from a Single Formulation with Tunable Release Profiles Through Control of Tablet Geometry.
Khaled SA; Alexander MR; Irvine DJ; Wildman RD; Wallace MJ; Sharpe S; Yoo J; Roberts CJ
AAPS PharmSciTech; 2018 Nov; 19(8):3403-3413. PubMed ID: 30097806
[TBL] [Abstract][Full Text] [Related]
13. Formulation of 3D Printed Tablet for Rapid Drug Release by Fused Deposition Modeling: Screening Polymers for Drug Release, Drug-Polymer Miscibility and Printability.
Solanki NG; Tahsin M; Shah AV; Serajuddin ATM
J Pharm Sci; 2018 Jan; 107(1):390-401. PubMed ID: 29066279
[TBL] [Abstract][Full Text] [Related]
14. Development of 3D DLP Printed Sustained Release Ibuprofen Tablets and Their Pharmacokinetic Evaluation in Rats.
Mosley-Kellum K; Bagde A; Spencer S; Dev S; Singh M
AAPS PharmSciTech; 2023 Mar; 24(4):88. PubMed ID: 36977867
[TBL] [Abstract][Full Text] [Related]
15. Fused-filament 3D printing (3DP) for fabrication of tablets.
Goyanes A; Buanz AB; Basit AW; Gaisford S
Int J Pharm; 2014 Dec; 476(1-2):88-92. PubMed ID: 25275937
[TBL] [Abstract][Full Text] [Related]
16. Photocurable poly(ethylene glycol) as a bioink for the inkjet 3D pharming of hydrophobic drugs.
Acosta-Vélez GF; Zhu TZ; Linsley CS; Wu BM
Int J Pharm; 2018 Jul; 546(1-2):145-153. PubMed ID: 29705105
[TBL] [Abstract][Full Text] [Related]
17. 3D printing of tablets using inkjet with UV photoinitiation.
Clark EA; Alexander MR; Irvine DJ; Roberts CJ; Wallace MJ; Sharpe S; Yoo J; Hague RJM; Tuck CJ; Wildman RD
Int J Pharm; 2017 Aug; 529(1-2):523-530. PubMed ID: 28673860
[TBL] [Abstract][Full Text] [Related]
18. Making tablets for delivery of poorly soluble drugs using photoinitiated 3D inkjet printing.
Clark EA; Alexander MR; Irvine DJ; Roberts CJ; Wallace MJ; Yoo J; Wildman RD
Int J Pharm; 2020 Mar; 578():118805. PubMed ID: 31715351
[TBL] [Abstract][Full Text] [Related]
19. Adaptation of pharmaceutical excipients to FDM 3D printing for the fabrication of patient-tailored immediate release tablets.
Sadia M; Sośnicka A; Arafat B; Isreb A; Ahmed W; Kelarakis A; Alhnan MA
Int J Pharm; 2016 Nov; 513(1-2):659-668. PubMed ID: 27640246
[TBL] [Abstract][Full Text] [Related]
20. Thermal Extrusion 3D Printing for the Fabrication of Puerarin Immediate-Release Tablets.
Li P; Jia H; Zhang S; Yang Y; Sun H; Wang H; Pan W; Yin F; Yang X
AAPS PharmSciTech; 2019 Dec; 21(1):20. PubMed ID: 31820224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
